Victor K. Ankoma-Sey
Expertise in
25
conditions

Dr. Victor K. Ankoma-Sey

Gastroenterology | Hepatology
10907 Memorial Hermann Dr, Ste 300, 
Pearland, TX 
Accepting New Patients
Expertise in
25
conditions
10907 Memorial Hermann Dr, Ste 300, 
Pearland, TX 

Overview

Victor Ankoma-Sey is a Gastroenterologist and a Hepatologist practicing medicine in Pearland, Texas.

Dr. Ankoma-Sey is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Failure, Cirrhosis, Liver Transplant, and Gastrostomy.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 7 clinical trials. Dr. Ankoma-Sey is currently accepting new patients.

Specialties

Gastroenterology
Hepatology

Licenses

Internal Medicine in TX

Fellowships

University of California (San Francisco) School of Medicine-Gastroenterology 1996

Hospital Affiliations

Houston Methodist Hospital
Memorial Hermann - Texas Medical Center
Houston Methodist The Woodlands Hospital
Houston Methodist Willowbrook Hospital
Houston Methodist Sugarland Hospital
Memorial Hermann Texas Medical Center

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

10907 Memorial Hermann Dr, Ste 300, Pearland, TX 77584
Other Locations
6560 Fannin St, Ste 1980, Houston, TX 77030

Additional Areas of Focus

Dr. Ankoma-Sey has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Enrollment Status: Completed
Publish Date: February 18, 2026
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Clinical Study of the BreathID® System to Train the Algorithm for the ¹³C-Octanoate Breath Test With or Without the ¹³C-Methacetin Breath Test (OBT and MBT Respectively) for Correlation With Histological Findings Associated With Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
Enrollment Status: Completed
Publish Date: December 20, 2022
Intervention Type: Device
Study Phase: Phase 2
Clinical Performance Evaluation of LIVERFASt Tests to Determine Fibrosis Staging, Inflammatory Activity and Steatosis Grading Compared w/ Liver Biopsy in Patients w/ Metabolic Factors & Presumed Non-Alcoholic Fatty Liver Disease (NAFLD).
Clinical Performance Evaluation of LIVERFASt Tests to Determine Fibrosis Staging, Inflammatory Activity and Steatosis Grading Compared w/ Liver Biopsy in Patients w/ Metabolic Factors & Presumed Non-Alcoholic Fatty Liver Disease (NAFLD).
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 6 Less Clinical Trials

13 Total Publications

Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: July 28, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Chukwuma I. Egwim
Gastroenterology | Hepatology
Expertise in
17
conditions
Dr. Chukwuma I. Egwim
Gastroenterology | Hepatology
Referral may be required
6560 Fannin St, Ste 1980, 
Houston, TX 
 (10.4 miles away)
713-799-8300
Languages Spoken:
English, Filipino, Spanish, Vietnamese
See accepted insurances
Accepting New Patients

Chukwuma Egwim is a Gastroenterologist and a Hepatologist practicing medicine in Houston, Texas. Dr. Egwim is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Hepatitis, Liver Failure, Visceromegaly, Liver Transplant, and Gastrostomy. Dr. Egwim is currently accepting new patients.

Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Houston Methodist Academic Medicine Associates-Hepatology

6445 Main St # 22, 
Houston, TX 
 (10.1 miles away)
713-441-4345
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Victor is a Hepatologist practicing medicine in Houston, Texas. Dr. Victor is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Enlarged Liver, Endoscopy, and Colonoscopy. Dr. Victor is currently accepting new patients.

Expertise in
26
conditions
Dr. Prasun K. Jalal
Transplant Surgery | Hepatology | Gastroenterology
Expertise in
26
conditions
Dr. Prasun K. Jalal
Transplant Surgery | Hepatology | Gastroenterology
Referral may be required
Before you request

Baylor St. Luke's Liver Center

6620 Main St, Ste 1450, 
Houston, TX 
 (10.3 miles away)
832-355-1400
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Prasun K. Jalal, M.D is Assistant Professor of Surgery in the Division of Abdominal Transplantation of the Michael E. DeBakey Department of Surgery and in the Department of Medicine, Section of Gastroenterology and Hepatology, at Baylor College of Medicine. Dr. Jalal is board certified in gastroenterology, internal medicine and transplant hepatology. Dr. Jalal earned his medical degree from Postgraduate Institute of Medical Education and Research, Chandigarh, India. His extensive training includes training in gastroenterology and hepatology at St. James Hospital in Leeds, England. He completed a fellowship in gastroenterology at Long Island Jewish Medical Center-Albert Einstein College of Medicine, New York and in transplant hepatology at Mount Sinai School of Medicine, New York. Dr. Jalal's clinical interests include viral hepatitis, liver transplant, liver cancer and autoimmune hepatitis. Dr. Jalal is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Hepatitis, Esophageal Varices, Hepatitis A, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Jalal is currently accepting new patients.

Frequently Asked Questions about Dr. Victor K. Ankoma-Sey

How do I make an appointment with Dr. Victor K. Ankoma-Sey?

You can book an appointment with Dr. Victor K. Ankoma-Sey by calling their office at 713-799-8300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Victor K. Ankoma-Sey a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Victor K. Ankoma-Sey is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Victor K. Ankoma-Sey specialize in?

While Dr. Victor K. Ankoma-Sey is a Gastroenterology, they have specific expertise in Hepatitis, Liver Failure, and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Victor K. Ankoma-Sey participate in research or clinical trials?

Yes. Dr. Victor K. Ankoma-Sey has published 13 articles and abstracts on conditions like Hepatitis. You can view a list of Dr. Victor K. Ankoma-Sey's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Victor K. Ankoma-Sey accept my insurance?

Dr. Victor K. Ankoma-Sey accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-799-8300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ankoma-Sey's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 15 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile